Pediatric Pulmonary Vascular Disease

Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes

Jae Kyoon Hwang, Seung Han Shin, Ee-Kyung Kim, Seh Hyun Kim, Han-Suk KimHanyang University Guri Hospital. Seoul National University College of Medicine.Republic of Korea Frontiers in PediatricsFront Pediatr 2023; 11: DOI: 10.3389/fped.2023.1108925 AbstractBackground: The definition of bronchopulmonary dysplasia (BPD) has been evolved recently from definition by the National Institute of Child Health and Human Development in 2001 […]

Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes Read More »

Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: A retrospective study in a medical center

Han-Pi Chang, Reyin Lien, Shih-Ming Chu, Jainn-Jim Lin, Ming-Chou ChiangChang Gung Memorial Hospital and Chang Gung University College of Medicine. New Taipei Municipal TuCheng Hospital. Taiwan Frontiers in PediatricsFront Pediatr 2023; 11: DOI: 10.3389/fped.2023.1055439 AbstractIntroduction: Bronchopulmonary dysplasia (BPD) with pulmonary hypertension (PH) leads to increased morbidity and mortality in extremely preterm infants. Recent studies have analyzed factors

Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: A retrospective study in a medical center Read More »

Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study

Roopa Siddaiah, Christiana Oji‐Mmuo, Vincent P. R. Aluquin, Yuka Imamura Kawasawa, Ann Donnelly, Dustin Rousselle, Nathalie Fuentes, Eric D. Austin, Patricia SilveyraPenn State Health and Children’s Hospital. Indiana University School of Public Health. Vanderbilt University.United States Pulmonary CirculationPulm Circ 2023; 13: DOI: 10.1002/pul2.12232 Abstract Pulmonary hypertension associated with bronchopulmonary dysplasia is a severe complication of preterm

Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study Read More »

Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes

Frank DiPaola, Andrew T. Trout, Ashley E. Walther, Anita Gupta, Rachel Sheridan, Kathleen M. Campbell, Greg Tiao, Jorge A. Bezerra, Kevin E. Bove, Manish Patel, Jaimie D. NathanC.S. Mott Children’s Hospital. Cincinnati Children’s Hospital Medical Center. University of Cincinnati Medical Center. Children’s Hospital Los Angeles.United States Digestive Diseases and SciencesDig Dis Sci 2020; 65: 1239-1251DOI: 10.1007/s10620-019-05834-w

Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes Read More »

Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes

Jai Khurana, Darren B. Orbach, Kimberlee Gauvreau, Shane A. Collins, Joseph B. Tella, Pankai B. Agrawal, Helen A. Christou, Mary P. MullenBoston Children’s Hospital, Boston. Harvard Medical School. Brigham & Women’s Hospital.United States Journal of PediatricsJ Pediatr 2023; DOI: 10.1016/j.jpeds.2023.113404 AbstractObjective: To assess the extent and resolution of pulmonary hypertension (PH), cardiovascular factors, and echocardiographic findings associated

Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes Read More »

Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future

Candice D. Fike, Judy L. AschnerUniversity of Utah Health. Joseph M. Sanzari Children’s Hospital at Hackensack University.United States PharmaceuticalsPharmaceuticals 2023; 16: DOI: 10.3390/ph16040503 AbstractApproximately 8-42% of premature infants with chronic lung disease of prematurity, bronchopulmonary dysplasia (BPD), develop pulmonary hypertension (PH). Infants with BPD-PH carry alarmingly high mortality rates of up to 47%. Effective PH-targeted pharmacotherapies

Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future Read More »

Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide

Mounya Duggal, Shiran S. Moore, Jessica Simoneau, Gabrielle Girard, Irene B. Gernet, Julia E. Von Oettingen, GuilhermeSant’Anna, Gabriel AltitMcGill University and Montreal Children’s Hospital. Canada American Journal of PerinatologyAm J Perinatol 2023; DOI: 10.1055/s-0043-1764385 AbstractObjective: This study aimed to evaluate the prevalence of adverse outcomes, specifically pulmonary hypertension (PH) and suspected or confirmed necrotizing enterocolitis (NEC), and

Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide Read More »

Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology

Ahmed Alalaiwe, Mohammad A. Alsenaidy, Ziyad S. Almalki, Mohamed H. FayedPrince Sattam Bin Abdulaziz University. King Saud University. Prince Sattam Bin Abdulaziz University. Fayoum University. Saudi Arabia PharmaceuticsPharmaceutics 2023; 15: DOI: 10.3390/pharmaceutics15030923 AbstractThe availability of age-appropriate oral dosage forms for pediatric patients has remained a challenge. Orodispersible mini-tablets (ODMTs) are a promising delivery system for pediatric

Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology Read More »

Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis

Fen Cao, Kun Wu, Yongzhi Zhu, Junjun Jiang, Gui Zhang, Jun Liu, Ping Xiao, Yang Tian, Wei Zhang, Sheng Zhang, Feng Hou, Zhongwu BaoHuaihua First People’s Hospital.China Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2023; 9: DOI: 10.3389/fcvm.2022.1055897 AbstractBackground: Pulmonary arterial hypertension (PAH) is a fatal disease characterized by pulmonary vascular remodeling and increased pulmonary artery pressure, leading

Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis Read More »

Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists

Sarah Chan, Rossa Brugha, Sadia Quyam, Shahin MoledinaGreat Ormond Street Hospital for Children. NHS Foundation Trust. University College London, London. United Kingdom BreatheBreathe 2022; 18: DOI: 10.1183/20734735.0209-2022 AbstractPulmonary hypertension (PH) can develop in babies with bronchopulmonary dysplasia (BPD). PH is common in those with severe BPD and is associated with a high mortality rate. However, in

Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists Read More »

Scroll to Top